Watch our on-demand webinar featuring toxicology expert Dr. Anthony Costantinoas he highlights the latest drug trends and the detection challenges these drugs pose to laboratories. During this webinar you will learn about:
- Evolving novel psychoactive substances (NPS)
- The risks and health concerns related to NPS
- Challenges laboratories face today
Speaker:
Dr. Costantino is a board-certified toxicologist and has over 30 years of experience in clinical, forensic, and analytical toxicology.
Dr. Costantino earned a Ph.D. in Forensic Toxicology at the University of Maryland, School of Medicine and is board certified by the American Board of Forensic Toxicology. He received his B.S. in Pharmacy and an M.S. in Pharmacology/Toxicology from Duquesne University in Pittsburgh, Pennsylvania.
Dr. Costantino is considered a thought leader in the field of toxicology and has authored over 30 scientific publications. He has served on numerous corporate and advisory boards and has served the SAMHSA Center for Drug Abuse Prevention’s Drug Testing Advisory Board (DTAB). He is a former President of the Society of Forensic Toxicologists, Inc. (SOFT), Dr. Costantino is also a Fellow of the American Board of Forensic Toxicology (ABFT).
He was most recently the President, CEO and Laboratory Director of DRUGSCAN, Inc. in Horsham, Pennsylvania. Prior to DRUGSCAN, Dr. Costantino was Vice President of Operations at NMS Labs, a national reference toxicology laboratory.
Dr. Costantino is currently adjunct faculty at Thomas Jefferson University and President of Costantino Consulting Services, Inc.
